Literature DB >> 2264322

Evaluation of monoclonal antibodies with putative specificity for human IgG allotypes.

P N Nelson1, S M Fletcher, G G de Lange, A M van Leeuwen, M Goodall, R Jefferis.   

Abstract

Fourteen monoclonal antibodies (MAbs) of putative specificity for human IgG allotypes and isoallotypes were evaluated for reactivity and specificity in 8 different assay systems. The study showed that the MAbs tested could be classified into 1 of 4 groups: those exhibiting allotypic specificity regardless of the assay system, allotypic specificity dependent on the assay system, isoallotypic specificity, and those showing neither allotypic nor isoallotypic specificity. These observations were presumably dependent on antigen presentation, epitope integrity and/or antibody multispecificity. For the G1m(a), G1m(f), G1m(z), G3m(g) and G3m(u) specificities, MAbs have been produced which can be used for routine typing purposes in defined haemagglutination and enzyme-linked immunosorbent assay systems. MAbs are also available that show 'non-g' isoallotypic specificity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2264322     DOI: 10.1111/j.1423-0410.1990.tb00858.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  4 in total

Review 1.  Monoclonal antibodies.

Authors:  P N Nelson; G M Reynolds; E E Waldron; E Ward; K Giannopoulos; P G Murray
Journal:  Mol Pathol       Date:  2000-06

2.  Production and characterization of new monoclonal antibodies to human osteoclasts.

Authors:  P N Nelson; J A Pringle; T J Chambers
Journal:  Calcif Tissue Int       Date:  1991-11       Impact factor: 4.333

3.  Gel test assay for IgG subclass detection by GM typing: application to hemolytic disease of the newborn.

Authors:  S J Alié-Daram; A Fournié; J M Dugoujon
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

4.  The first monoclonal anti-G1m(x) antibody: production and usefulness in haemagglutination-inhibition assay.

Authors:  G G De Lange; A M van Leeuwen
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.